Showing results (81-90 of 95) with videos related to
Sort By:
Pageof 10
Plos Genetics|March 8, 2012
A downstream CpG island controls transcript initiation and elongation and the methylation state of the imprinted Airn macro ncRNA promoterMartha V Koerner, Florian M Pauler, Quanah J Hudson, et al.Journal of Autoimmunity|October 2, 2017
A T cell-specific deletion of HDAC1 protects against experimental autoimmune encephalomyelitisLisa Göschl, Teresa Preglej, Patricia Hamminger, et al.Journal of Autoimmunity|February 23, 2021
Histone deacetylase 1 controls CD4+ T cell trafficking in autoinflammatory diseasesPatricia Hamminger, Luca Marchetti, Teresa Preglej, et al.Molecular Cancer|March 31, 2022
KMT2C methyltransferase domain regulated INK4A expression suppresses prostate cancer metastasisTanja Limberger, Michaela Schlederer, Karolina Trachtová, et al.Leukemia|April 2, 2025
HDAC1 acts as a tumor suppressor in ALK-positive anaplastic large cell lymphoma: implications for HDAC inhibitor therapyMaša Zrimšek, Kristina Draganić, Anna Malzer, et al.JCI Insight|February 28, 2020
Histone deacetylases 1 and 2 restrain CD4+ cytotoxic T lymphocyte differentiationTeresa Preglej, Patricia Hamminger, Maik Luu, et al.Journal of Autoimmunity|December 30, 2019
Histone deacetylase 1 (HDAC1): A key player of T cell-mediated arthritisLisa Göschl, Teresa Preglej, Nicole Boucheron, et al.Molecular Systems Biology|April 24, 2020
STAT3-dependent analysis reveals PDK4 as independent predictor of recurrence in prostate cancerMonika Oberhuber, Matteo Pecoraro, Mate Rusz, et al.Molecular Cancer|November 1, 2024
Cell-autonomous IL6ST activation suppresses prostate cancer development via STAT3/ARF/p53-driven senescence and confers an immune-active tumor microenvironmentChristina Sternberg, Martin Raigel, Tanja Limberger, et al.Plos Genetics|August 22, 2022
A toolbox for class I HDACs reveals isoform specific roles in gene regulation and protein acetylationLena Hess, Verena Moos, Arnel A Lauber, et al.Pageof 10